• Biofizik, Inc. was formed in 2016 by Simon Bergqvist as a resource for biophysical  binding approaches to enable small molecule and biotherapeutic drug discover & development and life sciences basic research.
• Prior to Biofizik, Inc. Simon led the biophysics group at the Pfizer, La Jolla Oncology Research Unit. This previous role supported a portfolio of drug discovery and development programs for small molecule and biotherapeutic drugs.
• Biofizik, Inc. has capabilities for small molecule and macromolecule binding studies with a particular emphasis on understanding the thermodynamic and kinetic underpinnings of binding interactions and applying them to support both drug discovery & development and basic science research.